PATENT CLAIM ANALYSIS

Application Number: 16289775
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

Claim (Index 9):
The liposome of  claim 8 , wherein the bisphosphonate has a bisphosphonate concentration range of 0.1 to 5 mg/ml within the liposome.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.73333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15974817', '13804707', '14713050', '13709005', '11842130']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7463202934768304
- 35 USC 102 Novelty (BERT): 0.5674070084542299
- Combined Prediction Score: 0.7284289649745703
- Mean Citation Score: 332.296638
- Max Citation Score: 449.38065
- Similarity Product: 368.40906896116735

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test